Production (Stage)
Black Diamond Therapeutics, Inc.
BDTX
$2.25
$0.2613.07%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Net Income | 106.38% | 15.48% | 13.09% | 2.67% | 7.79% |
| Total Depreciation and Amortization | -14.21% | -21.51% | -27.88% | -24.03% | -20.59% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 6.77% | -16.20% | -31.33% | -20.50% | -34.64% |
| Change in Net Operating Assets | -277.87% | -173.03% | 141.80% | 117.96% | 136.75% |
| Cash from Operations | 118.13% | 6.62% | 18.07% | 6.28% | 11.28% |
| Capital Expenditure | -- | -- | 100.00% | -512.50% | 82.16% |
| Sale of Property, Plant, and Equipment | 12.63% | -1.05% | -17.31% | -63.46% | 955.56% |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 275.87% | 3.62% | -78.54% | -165.82% | -136.12% |
| Cash from Investing | 276.85% | 3.81% | -77.44% | -165.68% | -136.12% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -71.47% | -64.16% | -64.56% | 94,497.09% | 73,741.75% |
| Repurchase of Common Stock | -447.83% | -447.83% | -964.29% | -64.29% | -64.29% |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -71.78% | -64.48% | -64.96% | 129,752.00% | 101,248.00% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 618.94% | -191.78% | -1,041.56% | 31.92% | 6.18% |